Drug resistance to inhibitors of the human double minute-2 E3 ligase is mediated by point mutations of p53, but can be overcome with the p53 targeting agent RITA.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Robert Z Orlowski |
| Publication date | August 28, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |